E-cadherin is a WT1 target gene

被引:102
作者
Hosono, S
Gross, I
English, MA
Hajra, KM
Fearon, ER
Licht, JD
机构
[1] CUNY Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA
[3] CUNY Mt Sinai Sch Med, Dept Biochem & Mol Biol, New York, NY 10029 USA
[4] Univ Michigan, Med Ctr, Dept Internal Med, Div Med & Mol Genet, Ann Arbor, MI 48109 USA
关键词
D O I
10.1074/jbc.275.15.10943
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The WT1 tumor suppressor gene encodes a transcription factor that can activate and repress gene expression. Transcriptional targets relevant for the growth suppression functions of WT1 are poorly understood. We found that mesenchymal NIH 3T3 fibroblasts stably expressing WT1 exhibit growth suppression and features of epithelial differentiation including up-regulation of E-cadherin mRNA. Acute expression of WT1 in NIH 3T3 fibroblasts after retroviral infection induced murine E-cadherin expression. In transient transfection experiments, the human and murine E-cadherin promoters were activated by co-expression of WT1. E-cadherin promoter activity was increased in cells overexpressing WT1 and was blocked by a dominant negative form of WT1. WT1 activated the murine E-cadherin promoter through a conserved GC-rich sequence similar to an EGR-1 binding site as well as through a CAAT box sequence. WT1 produced in vitro or derived from nuclear extracts bound to the WT1-response element within the murine E-cadherin promoter, but not the CAAT box. E-cadherin, a gene important in epithelial differentiation and neoplastic transformation, represents a downstream target gene that links the roles of the WT1 in differentiation and growth control.
引用
收藏
页码:10943 / 10953
页数:11
相关论文
共 79 条
[71]   ALLELE LOSS ON CHROMOSOME-16 ASSOCIATED WITH PROGRESSION OF HUMAN HEPATOCELLULAR-CARCINOMA [J].
TSUDA, H ;
ZHANG, WD ;
SHIMOSATO, Y ;
YOKOTA, J ;
TERADA, M ;
SUGIMURA, T ;
MIYAMURA, T ;
HIROHASHI, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6791-6794
[72]   CELL-ADHESION MOLECULE UVOMORULIN DURING KIDNEY DEVELOPMENT [J].
VESTWEBER, D ;
KEMLER, R ;
EKBLOM, P .
DEVELOPMENTAL BIOLOGY, 1985, 112 (01) :213-221
[73]   A 2ND TRANSCRIPTIONALLY ACTIVE DNA-BINDING SITE FOR THE WILMS-TUMOR GENE-PRODUCT, WT1 [J].
WANG, ZY ;
QIU, QQ ;
ENGER, KT ;
DEUEL, TF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :8896-8900
[74]  
WANG ZY, 1995, ONCOGENE, V10, P415
[75]  
WANG ZY, 1993, J BIOL CHEM, V268, P9172
[76]  
WANG ZY, 1992, J BIOL CHEM, V267, P21999
[77]  
WERNER H, 1995, MOL CELL BIOL, V15, P3516
[78]   INCREASED EXPRESSION OF THE INSULIN-LIKE GROWTH FACTOR-I RECEPTOR GENE, IGF1R, IN WILMS-TUMOR IS CORRELATED WITH MODULATION OF IGF1R PROMOTER ACTIVITY BY THE WT1 WILMS-TUMOR GENE-PRODUCT [J].
WERNER, H ;
RE, GG ;
DRUMMOND, IA ;
SUKHATME, VP ;
RAUSCHER, FJ ;
SENS, DA ;
GARVIN, AJ ;
LEROITH, D ;
ROBERTS, CT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5828-5832
[79]   Tumor suppressor p53 can participate in transcriptional induction of the GADD45 promoter in the absence of direct DNA binding [J].
Zhan, QM ;
Chen, IT ;
Antinore, MJ ;
Fornace, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (05) :2768-2778